These restrictions of the BTNX NTS are really related, as we identified e.g. etodesnitazene to acquire a similar in vitro potency and efficacy as fentanyl [7, thirteen] and as it may potentially give PWUD a Wrong perception of protection. Moreover, the detectability of nitazene analogues in drug samples may very well be impacted by solubility probl